Format

Send to:

Choose Destination

Links from GEO Profiles

Full record GDS2971

Hemiasterlin analog HTI-286 effect on docetaxel-resistant prostate cancer cell line

Analysis of prostate cancer LNCaP cells treated with the chemotherapeutic agent docetaxel or the hemiasterlin analog HTI-286. Like docetaxel, HTI-286 disrupts microtubule dynamics. But unlike docetaxel, HT-286 exhibits reduced multidrug resistance.
Organism:
Homo sapiens
Type:
Expression profiling by array, log2 ratio, 2 agent sets
Platform:
GPL3877
Series:
GSE8325
12 Samples
Download data
DataSet
Accession:
GDS2971
ID:
2971

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center